23andme Holding CO Form 4 insider transactions

Chrome Holding Co.'s CEO, CFO, and CAO, Joseph Selsavage, reported the disposition of 5,232 shares of Class A Common Stock.

Anne Wojcicki, a Director and 10% owner of 23andMe Holding Co., converted 4,931,692 shares of Class B Common Stock into Class A Common Stock on June 9, 2025.

Joseph Selsavage, Interim CEO, CFO, and CAO of 23andMe Holding Co., disposed of shares to satisfy tax withholding obligations related to equity awards.

Joseph Selsavage, CFO of 23andMe Holding Co., disposed of 5,654 shares of Class A Common Stock on February 20, 2025, to cover tax obligations.

23andMe's Chief Financial Officer, Joseph Selsavage, disposed of 5,279 shares of Class A Common Stock to cover tax obligations.

Richard Scheller, a director at 23andMe Holding Co., filed a Form 4 disclosing the acquisition and disposition of Class A Common Stock on August 26, 2024.

Valerie Montgomery Rice, a director at 23andMe Holding Co., reported acquiring Class A Common Stock through restricted stock units (RSUs) and in lieu of cash retainer fees.

Director Neal Mohan reports the acquisition and disposition of 23andMe Holding Co. Class A Common Stock.

Director Patrick Chung reports acquisition and disposal of Class A Common Stock and Restricted Stock Units (RSUs) in 23andMe Holding Co.

Roelof Botha, a director of 23andMe Holding Co., reported the acquisition of Class A Common Stock and Restricted Stock Units (RSUs) in a recent SEC filing.

Director Peter Taylor reports acquisition of stock awards and disposal of shares in 23andMe Holding Co.

Director Sandra Hernandez reports acquisition and disposal of 23andMe Class A Common Stock, including restricted stock units (RSUs) and shares in lieu of cash retainer fees.

Joseph Selsavage, CFO of 23andMe Holding Co., disposed of shares to cover tax obligations arising from equity compensation.

William G. Richards, Head of Therapeutics Discovery at 23andMe, disposed of 57,365 shares of Class A Common Stock to cover tax obligations.

Director Peter Taylor reports the acquisition and disposal of Class A Common Stock and grants power of attorney for SEC filings.

Director Valerie Montgomery Rice reports the acquisition of Class A Common Stock in 23andMe Holding Co. through restricted stock units (RSUs) and defers receipt of shares.

Director Sandra Hernandez reports the acquisition of 57,515 shares of 23andMe Class A Common Stock and the deferral of receipt of these shares under the company's RSU Conversion and Deferral Program for Directors.

Joseph Selsavage, CFO of 23andMe Holding Co., was granted 1,000,000 restricted stock units (RSUs) that vest quarterly starting August 20, 2024.

Kathy L Hibbs, Chief Administrative Officer of 23andMe Holding Co., reports the disposition of 35,282 shares of Class A Common Stock to cover tax obligations.

Interim CFO Joseph Anthony Selsavage disposed of shares of 23andMe Holding Co. to cover tax obligations resulting from vested equity.

William G. Richards, Head of Therapeutics Discovery at 23andMe, reports the disposition of 16,106 shares of Class A Common Stock to cover tax obligations.

Kathy L. Hibbs, Chief Administrative Officer of 23andMe Holding Co., sold 38,551 shares of Class A Common Stock at an average price of $0.4941 on May 2, 2024, under a pre-arranged trading plan.

Kathy L. Hibbs, Chief Administrative Officer of 23andMe Holding Co., executed a sale of company stock on April 18, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Kathy Hibbs, Chief Administrative Officer of 23andMe Holding Co., reports the acquisition and disposal of Class A Common Stock and stock options on April 4, 2024, pursuant to a pre-arranged trading plan.

Kathy Hibbs, Chief Administrative Officer of 23andMe Holding Co., reports exercising stock options and selling shares under a pre-arranged Rule 10b5-1 trading plan.

Kathy Hibbs, Chief Administrative Officer of 23andMe Holding Co., reports the exercise of stock options and subsequent sale of shares under a pre-arranged trading plan.